Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (RO1DK104344, 1U19AI082655)
Egan Family Foundation
Received: 4 November 2018
Accepted: 24 April 2019
First Online: 7 May 2019
: R.F., G.S., L.I., R.S., M.C. declare no competing interests. S.S. declares the following financial relationship: stock holder of Array Biopharma Inc.; A.A. is currently employed at PatientsLikeMe, Inc., Cambridge; A.S. is currently employed at Takeda Pharmaceuticals International Co. as associate medical director and received consultancy fees from Inova Diagnostics Inc.; A.F. declares the following financial relationships: stock holder of Alba Therapeutics, advisory board committee member at Axial Biotherapeutics and uBiome; consultant at Inova Diagnostics Inc. and Innovate Biopharmaceuticals, Inc., speaker agreement with Mead Johnson Nutrition.